ACQUIREDT+2Regeneron Pharmaceuticals · NASDAQ+12,282 sh · $4.7MFiled 21 Aug 2026·SEC Form 4·view source
REDUCEDT+2Regeneron Pharmaceuticals · NASDAQ−9,019 sh · $7.5MFiled 21 Aug 2026·SEC Form 4·view source